1. Summarize the techniques used to assess Alzheimer’s disease proteinopathy including

imaging and biofluids.

2. Describe the biological processes that appear to drive cognitive decline and their

temporal scale in the presymptomatic stage of Alzheimer’s disease.

3. Compare the relative value of a biological definition of AD to a clinical definition.

Session date: 
06/28/2024 - 10:00am to 11:00am CDT
Location: 
Virtual
United States
See map: Google Maps
  • 1.00 APA CE Credits
  • 1.00 University of Wisconsin–Madison Continuing Education Hours
    • 1.00 Approved for AMA PRA Category 1 Credit™
Add to calendar: 

Please login or register to take this course.
Discloser List CME Internal Report